
Rozytide 50mcg Injection
Marketer
Blismed Pharmaceuticals Pvt. Ltd
Salt Composition
Octreotide acetate (50mcg)
Overview Rozytide 50mcg Injection
Rozytide 50mcg Injection treats acromegaly, carcinoid tumors, and bleeding esophageal varices, and helps prevent post-pancreatic surgery complications. Administration is exclusively by a healthcare provider; self-injection is prohibited. Dosage and frequency are determined by your physician. Consistent use maximizes therapeutic effect; discontinue only as directed by your doctor. Common side effects include diarrhea, abdominal pain, nausea, constipation, gas, and headache. Report persistent or worsening side effects. Prior to treatment, disclose any liver conditions and all other medications you are currently using.
Uses of Rozytide 50mcg Injection
Overgrowth of tissues (acromegaly), carcinoid cancers, and esophageal variceal hemorrhage.
Major Benefits of Rozytide 50mcg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Rozytide 50mcg Injection:
- Diarrhea
- Abdominal pain
- Nausea
- Constipation
- Flatulence
- Headache
- Increased glucose level in blood
- Injection site reaction
How to use Rozytide 50mcg Injection:
Administering this medication will be handled by your healthcare provider; self-medication is strongly discouraged.
How Rozytide 50mcg Injection works:
Rozytide 50mcg Injection mimics the action of somatostatin, a naturally occurring human hormone regulator. This medication counteracts the activity of specific hormones, including growth hormone, and reduces esophageal bleeding via vasoconstriction.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Rozytide 50mcg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Rozytide (50mcg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences to fetal development; nevertheless, clinical data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Rozytide 50mcg Injection while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingSAFE
Administration of Rozytide 50mcg Injection typically does not impair driving capabilities.
KidneySAFE IF PRESCRIBED
The administration of Rozytide 50mcg Injection presents no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
Patients with liver impairment should use Rozytide 50mcg Injection cautiously; dose modification may be necessary. Physician consultation is recommended.
What if you forget to take Rozytide 50mcg Injection :
Should you forget a Rozytide 50mcg Injection, administer it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Rozytide 50mcg Injection
| Label | Value |
|---|---|
| Chemical Classification | Somatostatin analogs |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Behavioral Class | Somatostatin receptor ligands |
